Pneumococcal Vaccines for Developing Countries

Having witnessed the enormous impact of a vaccine that essentially eradicated meningitis due to Haemophilus influenza type b (Hib) in the United States, Dr. Richard Malley, MD, Senior Associate Physician in Medicine at Children's, set out to develop an effective pneumococcal vaccine that would be designed for use in countries in the developing world.

Working for over ten years with a number of colleagues, including his mentor, Dr. Porter Anderson, the co-inventor of the Hib conjugate vaccine, Dr. Malley has developed two vaccine strategies and is gearing up to test these vaccines in the clinic.

In this interview, we had the chance to sit down with Dr. Malley and discuss his team's strategies to develop these vaccines, the development and collaborations they set up to further this goal, and the future developments needed to make their vision a reality.

Category:

Science & Technology

Tags:

• Dr. Richard Malley
• Dr. Porter Anderson
• Haemophilus influenza
• Hib conjugate vaccine
• vaccination
• vaccines
• Children's Hospital Boston